First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer

BACKGROUND: There are limited comparisons of first- and second-generation EGFR tyrosine kinase inhibitors (TKIs) in large, real-world cohorts of non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations. METHODS: Patients with advanced NSCLC (N = 612) with co...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Allen Chung-Cheng, Huang, Chi-Hsien, Ju, Jia-Shiuan, Chiu, Tzu-Hsuan, Tung, Pi-Hung, Wang, Chin-Chou, Liu, Chien-Ying, Chung, Fu-Tsai, Fang, Yueh-Fu, Guo, Yi-Ke, Kuo, Chih-Hsi Scott, Yang, Cheng-Ta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326821/
https://www.ncbi.nlm.nih.gov/pubmed/34377157
http://dx.doi.org/10.1177/17588359211035710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326821/
https://www.ncbi.nlm.nih.gov/pubmed/34377157
http://dx.doi.org/10.1177/17588359211035710

Ejemplares similares